Göttingen

RG6501 (OpRegen®) Preclinical Engraftment Results to Be Presented at 2024 Association for Research in Vision and Ophthalmology Meeting

Retrieved on: 
Monday, March 11, 2024

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that preclinical results as part of a surgical development study evaluating the survival and distribution of RG6501 ( OpRegen ) will be presented at the 2024 Association for Research in Vision and Ophthalmology Annual Meeting (2024 ARVO) .

Key Points: 
  • Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that preclinical results as part of a surgical development study evaluating the survival and distribution of RG6501 ( OpRegen ) will be presented at the 2024 Association for Research in Vision and Ophthalmology Annual Meeting (2024 ARVO) .
  • The meeting will be held May 5-9, 2024, in Seattle, WA.
  • The presentation, “OpRegen engrafts within the retinal pigmented epithelium (RPE) of Gottingen mini-pigs by 4-weeks post-administration via subretinal delivery,” will be presented by Rachel N. Andrews, DVM, PhD, DACVP, Principal Scientist-Pathologist, Safety Assessment, Genentech, a member of the Roche Group, on behalf of Roche and Genentech .

Gotion High-tech Releases 2022 Interim Results

Retrieved on: 
Friday, August 26, 2022

Revenue in the first half of the year amounted to RMB8,638 million, and R&D expense doubled again, up 104.97% year-on-year

Key Points: 
  • Revenue in the first half of the year amounted to RMB8,638 million, and R&D expense doubled again, up 104.97% year-on-year
    HONG KONG, Aug 26, 2022 - (ACN Newswire) - Gotion High-tech Co., Ltd. ("Gotion High-tech" or the "Company"; Stock Code: 002074.SZ) announced its interim results for the six months ended 30 June 2022 (the "Reporting Period").
  • During the Reporting Period, Gotion High-tech generated revenue mainly from power lithium battery, energy storage battery and power transmission and distribution equipment.
  • Since the start of 2022, China further emphasized its support for the accelerated development of new energy industry as a strategic emerging industry.
  • In the first half of 2022, Gotion High-tech's R&D expense amounted to RMB510 million, an increase of 104.97% year-on-year.

ShiftLeft to Present at No Hat Conference 2021

Retrieved on: 
Wednesday, November 17, 2021

In this talk, they will present ghidra2cpg, an extension for the open-source code mining platform Joern that enables it to process binary code.

Key Points: 
  • In this talk, they will present ghidra2cpg, an extension for the open-source code mining platform Joern that enables it to process binary code.
  • Claudiu-Vlad Ursache is a Security Research Engineer at ShiftLeft, having recently entered cybersecurity after a decade of writing software.
  • Backed by Bain Capital Ventures, Mayfield, Thomvest Ventures, and SineWave Ventures, ShiftLeft is based in Santa Clara, CA.
  • To learn how ShiftLeft keeps AppSec in sync with the rapid pace of DevOps, see https://www.shiftleft.io/ .

Precision Contracting Solutions Files Lawsuit Against American University And Natalie Delgadillo For Libel, Tortious Interference With Business Relations And Conspiracy

Retrieved on: 
Wednesday, June 24, 2020

View Lawsuit

Key Points: 
  • View Lawsuit
    "Delgadillois accused of violatingthe Fair Report Privilege as AU executives turned a blind eye to her unconscionable and reckless behavior," said Stephen Sieber, a Plaintiff in the lawsuit.
  • "The reckless conduct of Delgadillo and American University have wrongfully defamed me and my company that took me over a decade to build," said Precision Contracting Solutions owner Derrick Sieber.
  • Delgadillo Declaration
    The Office of the Attorney General is also being sued, as is AG Karl A. Racine and Assistant AG Richard Rodriguez personally.
  • Delgadillo's actions were and continue to be supported by American University which is a disgrace to the institutions core principals of integrity and honor," Stephen Sieber said.

Rotenberg Associates and Scott Public Relations Announce Strategic Alliance

Retrieved on: 
Tuesday, October 8, 2019

Los Angeles-based Scott Public Relations and Washington, D.C.-based Rotenberg Associates , today announced a strategic affiliation to provide specialized communications expertise in healthcare with presence and influence in the nations capital.

Key Points: 
  • Los Angeles-based Scott Public Relations and Washington, D.C.-based Rotenberg Associates , today announced a strategic affiliation to provide specialized communications expertise in healthcare with presence and influence in the nations capital.
  • View the full release here: https://www.businesswire.com/news/home/20191008005393/en/
    Amy Rotenberg, Esq, Founder and President of Rotenberg Associates, and I have collaborated for the past five years and this closer affiliation is a logical next step, said Joy Scott, MBA, President and CEO of Scott Public Relations.
  • The Rotenberg Associates team brings together the expertise of senior level public affairs, former journalists, and communications professionals to provide dynamic, comprehensive and results-oriented public relations for its clients.
  • Please visit Scott Public Relations at: http://www.scottpublicrelations.com/ and Rotenberg Associates LLC at: www.rotenbergassoc.com
    View source version on businesswire.com: https://www.businesswire.com/news/home/20191008005393/en/